Medicare paid almost $100M to dead doctors since 2000, report finds
Since 2000, Medicare has paid out as much as $92 million to DME providers for equipment prescribed by doctors who were dead at the time, a Congressional investigation has found. During that period, CMS paid about 500,000 such claims, despite becoming aware of this form of fraud in 2001 when the HHS Office of the Inspector General identified it. This report is part of a broader investigation into Medicare waste, abuse and fraud being conducted by the Senate Homeland Security and Governmental Affairs Committee's subcommittee on investigations.
Investigators discovered the problem when they ran a check matching American Medical Association lists of physicians who died between 1992 and 2002. They randomly selected 1,500 of the deceased physicians, then checked Medicare claims filed between 2000 and 2007 for those doctors' Medicare ID numbers. During that period, ID numbers for 734 dead doctors were used to file 21,458 claims totaling $3.4 million. Using these numbers, investigators estimated that 384,730 to 572,238 such illegal claims were submitted during that period. They also noted that there are still active ID numbers in the Medicare system for up to 2,895 physicians, leaving the door open for future fraud.
To learn more about the investigation:
- read this Washington Post piece
Related Articles:
Medicare fraud costs CMS billions
New HHS program targets Medicare fraud
Medicare fraud growing due to design of IT systems
Is this how CMS should fight Medicare fraud?
Comments
Just as technology is the great enabler when it comes to committing fraud of any kind, medical included, technology should also be the greatest tool in the hands of auditors and investigators in combatting this fraud.
It just doesn't seem that there is any sense of urgency on the part of government fraud investigators - investigating a problem that has been going on for the past 7 years (at least) and just now discussing how to deal with it, and still at the discussion stage at that - this is no deterrent to current and future fraudsters.
Post new comment
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies




